Buddy Guise Latest Posts

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Reuniting with a Beloved Pet In an inspiring tale of loyalty and perseverance, a two-and-a-half-year-old Siamese cat named Rayne Beau captured attention after reuniting with his dedicated owners, Susanne and Benny Anguiano. After mysteriously wandering off during their trip, this fluffy companion undertook an extraordinary journey of over 900 miles to return home, taking...

Teknova and Pluristyx Partnership for Cell Therapy Innovation HOLLISTER, Calif. – Teknova, known for its critical reagents in life sciences, has joined forces with Pluristyx to enhance the manufacturing of next-generation cell therapies. This collaboration aims to produce and distribute the PluriFreeze™ product line, which serves as both a cryopreservative and cell...

XP Inc. Investors Considering Class Action Lawsuit XP Inc. (NASDAQ: XP) has found itself at the center of a significant legal inquiry, as investors are encouraged to consider the implications of recent allegations against the company. This analysis sheds light on the potential for a class action lawsuit, which could provide a vital avenue for shareholders to seek redress...

Federal Reserve's Review of Discount Window Operations The Federal Reserve is actively seeking public input on its emergency lending tool, known as the "discount window." This mechanism is specifically intended to assist banks during difficult financial times. Objectives of the Feedback Solicitation On a recent Thursday, the Fed announced its plan to gather comments...

The Roller Coaster Ride of Bitcoin in 2025 The first half of 2025 has been an exhilarating journey for Bitcoin, marked by extreme volatility and dramatic shifts in market sentiment. Following its historic peaks and valleys, Bitcoin has once again captured the attention of both retail and institutional investors alike. From All-Time Highs to Big Dips Bitcoin recently shot...